Skip to content
  • Tuesday, 27 October 2026
  • 9:35 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Groundbreaking Autopsy Study Provides Definitive Evidence Linking Amyloid Clearance to Reduced Alzheimer’s Pathology
Neuroscience & Brain Research

Groundbreaking Autopsy Study Provides Definitive Evidence Linking Amyloid Clearance to Reduced Alzheimer’s Pathology

Rifan Muazin Oct 16, 2026 0

In a landmark case study that has sent ripples through the neurological community, researchers from the Perelman School of Medicine…

Read More
Neuroscience & Brain Research

Beyond Amyloid Beta: A New Frontier in Alzheimer’s Disease Research Challenges Decades of Scientific Dogma

Rifan Muazin Oct 15, 2026 0

For over thirty years, the global scientific community has operated under a monolithic paradigm regarding the pathogenesis of Alzheimer’s disease,…

Read More
Neuroscience & Brain Research

Beyond Amyloid and Tau: Researchers Uncover 3D Genome Reorganization as a New Frontier in Alzheimer’s Disease Pathology

Rifan Muazin Sep 13, 2026 0

A landmark collaborative study led by researchers at Carnegie Mellon University (CMU), the University of Pittsburgh School of Medicine, and…

Read More
Neuroscience & Brain Research

Competition Between Amyloid Beta and Tau for Microtubule Binding Sites Offers New Insight into the Early Pathogenesis of Alzheimer’s Disease

Rifan Muazin Jun 27, 2026 0

Researchers at the University of California, Riverside (UCR) have unveiled a provocative new theory regarding the molecular origins of Alzheimer’s…

Read More
Neuroscience & Brain Research

Baylor College of Medicine Researchers Identify Sox9 Protein as Key to Clearing Amyloid Plaques and Preserving Memory in Alzheimer’s Models

Rifan Muazin May 17, 2026 0

In a landmark study that shifts the focus of neurodegenerative research from neurons to the brain’s intrinsic support system, scientists…

Read More
Pharmaceutical R&D

Cochrane Review Challenges Clinical Significance of Anti-Amyloid Alzheimer’s Drugs, Pharmaceutical Companies Reaffirm Efficacy

Teuku Ryan Apr 18, 2026 0

A comprehensive review of 17 clinical trials by the esteemed Cochrane organization has cast doubt on the clinically meaningful benefits…

Read More
Neuroscience & Brain Research

Engineering Astrocytes as a Novel Cellular Immunotherapy for the Eradication of Amyloid Plaques in Alzheimer’s Disease

Rifan Muazin Apr 6, 2026 0

Researchers at Washington University School of Medicine in St. Louis have unveiled a breakthrough in neurodegenerative research that could fundamentally…

Read More
Neuroscience & Brain Research

Washington University Researchers Develop Single Injection Cellular Immunotherapy to Target Alzheimer’s Disease Amyloid Plaques

Rifan Muazin Mar 20, 2026 0

The landscape of neurodegenerative disease research has reached a pivotal turning point as scientists move beyond symptom management toward therapies…

Read More
The largest invertebrate known was an enormous octopus that lived at the time of dinosaursUnlocking the Molecular Blueprint of Male Infertility: Japanese Researchers Discover Vital Protein Interaction Governing Sperm DevelopmentA New Dimension of Alzheimer’s Disease: Researchers Uncover Genome Folding Defects as a Key Driver of Neurological DeclineIsland Wolves Rewrite Ancient Human-Wolf Dynamics
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ